Zinc in the Pathophysiology and Treatment of Acne Vulgaris: Clinical Efficacy, Molecular Mechanisms, Safety Profile, and Future Therapeutic Perspectives – A Comprehensive Literature Review

Background: Acne vulgaris is a chronic inflammatory disease of the pilosebaceous unit involving sebum overproduction, follicular hyperkeratinization, Cutibacterium acnes colonization, and immune dysregulation. Zinc may reduce sebum, exert antibacterial and anti-inflammatory effects, and support wound healing. Aim of the study: This review summarizes evidence on zinc in acne vulgaris, including its mechanisms, clinical effectiveness, safety, biomarker potential, effects on antibiotic resistance, scar healing and sebum production, and treatment costs. Methods: PubMed was searched up to 2026. Clinical trials, meta-analyses, and mechanistic studies evaluating oral and topical zinc in acne were reviewed, with emphasis on serum zinc levels, efficacy versus standard therapies, safety, antibiotic resistance, scarring, sebum and androgen modulation, zinc transporter genetics, and costs. Results: Patients with acne often have lower serum zinc levels than healthy controls, particularly in severe disease, suggesting potential as a biomarker. Oral zinc modestly reduces inflammatory lesions but is less effective than tetracyclines and isotretinoin; topical zinc mainly provides adjunctive benefit. Both forms have favorable safety profiles. Zinc does not induce C. acnes antibiotic resistance and may reduce antibiotic use. It may support scar healing and decrease sebum partly through 5α-reductase inhibition. Evidence on zinc transporter genetics remains limited. Zinc is generally inexpensive, but robust cost-effectiveness data are lacking. Conclusions: Zinc is a safe, accessible adjunctive option for acne vulgaris, particularly inflammatory lesions, but is less effective than established first-line therapies. Further standardized trials are needed to define optimal dosing, formulations, and patient selection.

Authors

Institutions

Publication Details

Journal
Quality in Sport
Published
2026-11-13
DOI
https://doi.org/10.12775/qs.2026.79.76733
Primary Topic
Acne and Rosacea Treatments and Effects
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Zinc in the Pathophysiology and Treatment of Acne Vulgaris: Clinical Efficacy, Molecular Mechanisms, Safety Profile, and Future Therapeutic Perspectives – A Comprehensive Literature Review

Jakub Jopek, Klaudia Kwolek, Lukasz Wąs, Sebastian Ożga et al.
Quality in Sport
Acne and Rosacea Treatments and Effects
article

Zinc in the Pathophysiology and Treatment of Acne Vulgaris: Clinical Efficacy, Molecular Mechanisms, Safety Profile, and Future Therapeutic Perspectives – A Comprehensive Literature Review

Jakub Jopek, Klaudia Kwolek, Lukasz Wąs, Sebastian Ożga, Aleksandra Biolik, Bartłomiej Brzostowski
article en

Abstract

Background: Acne vulgaris is a chronic inflammatory disease of the pilosebaceous unit involving sebum overproduction, follicular hyperkeratinization, Cutibacterium acnes colonization, and immune dysregulation. Zinc may reduce sebum, exert antibacterial and anti-inflammatory effects, and support wound healing. Aim of the study: This review summarizes evidence on zinc in acne vulgaris, including its mechanisms, clinical effectiveness, safety, biomarker potential, effects on antibiotic resistance, scar healing and sebum production, and treatment costs. Methods: PubMed was searched up to 2026. Clinical trials, meta-analyses, and mechanistic studies evaluating oral and topical zinc in acne were reviewed, with emphasis on serum zinc levels, efficacy versus standard therapies, safety, antibiotic resistance, scarring, sebum and androgen modulation, zinc transporter genetics, and costs. Results: Patients with acne often have lower serum zinc levels than healthy controls, particularly in severe disease, suggesting potential as a biomarker. Oral zinc modestly reduces inflammatory lesions but is less effective than tetracyclines and isotretinoin; topical zinc mainly provides adjunctive benefit. Both forms have favorable safety profiles. Zinc does not induce C. acnes antibiotic resistance and may reduce antibiotic use. It may support scar healing and decrease sebum partly through 5α-reductase inhibition. Evidence on zinc transporter genetics remains limited. Zinc is generally inexpensive, but robust cost-effectiveness data are lacking. Conclusions: Zinc is a safe, accessible adjunctive option for acne vulgaris, particularly inflammatory lesions, but is less effective than established first-line therapies. Further standardized trials are needed to define optimal dosing, formulations, and patient selection.

Quality in SportVol. 79
Medical University of Silesia (PL)
Acne and Rosacea Treatments and Effects
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon